Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Director Leon Recanati Buys $400K Stake, Backs Incumbent Board in Proxy Fight

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.68
Mkt Cap
$9.991M
52W Low
$0.37
52W High
$1.5
52W Position info
84% above low
Off High info
55% below high
Rel. Volume info
4.0× avg
Market data snapshot near publication time

EVGN sits 84% above its 52-week low of $0.37 on elevated volume (4.0× avg).

Summary

Evogene director Leon Recanati purchased $400K of stock and pledged to vote for the incumbent board in the September 4 proxy fight against an activist group holding 17.4%.


Key Events · Ownership and Investor Activity · EVGN

  • Director Buys $400K Stake

    Leon Recanati purchased 800,000 shares at $0.50 each, increasing his beneficial ownership to 894,836 shares (5.7% of outstanding).

  • Votes Pledged for Incumbent Board

    Recanati will vote all his shares for the current board's nominees at the September 4, 2026 AGM, opposing the activist slate that holds 17.4%.

  • Proxy Battle Context

    The activist group has been buying shares since July and now holds 17.41%, demanding board replacement. Recanati's purchase and voting commitment strengthens the incumbent position.

  • Financial Impact

    The $400,000 purchase represents a significant personal investment relative to the company's ~$10M market cap, signaling strong insider conviction.


Analysis · EVGN · Industrial Applications And Services

In a high-stakes move ahead of the September 4 AGM, Director Leon Recanati has purchased 800,000 shares for ~$400,000 at $0.50 per share, lifting his stake to 5.7%. He is publicly committing to vote all his shares for the incumbent board, directly opposing the activist group that holds 17.4% and seeks to replace most directors. This real-money endorsement from an insider with a board seat materially shifts the voting dynamics in the proxy battle.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $0.68 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $10M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.2875 info
Change: -$0.1226 (-30%) info
Market Cap: $5.19M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.2875 info
Change: -$0.1293 (-31%) info
Market Cap: $5.19M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.2875 info
Change: -$0.1032 (-26%) info
Market Cap: $5.19M info
EVGN
Sep 15, 2026, 5:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.5281
Real-time Price: $0.2875 info
Change: -$0.2406 (-46%) info
Market Cap: $5.19M info
EVGN
Sep 11, 2026, 6:31 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $0.4728
Real-time Price: $0.2875 info
Change: -$0.1853 (-39%) info
Market Cap: $5.19M info